Company / AR per Share
AbbVie AR per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$7.10
FY2025
5-year range
$6.14 / $7.10
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#10 of 115
Health Care
What the data says
Among 115 Health Care companies, AbbVie is in the top 9% for ar per share. AR per Share returned to growth in FY2025 after 2 years of decline, reaching $7.10.
Based on SEC 10-K filings.
7.10 in FY2025 with a 5-year CAGR of +4.5%. Top quartile in the Health Care sector.
Improved from $6.28 to $7.10 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +1.8%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 115This company $7.10 Sector average $27.09
▼
-73.8% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 15.6% year-over-year.
- Ranks #10 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.10 | +15.6% |
| FY2024 | $6.14 | -2.2% |
| FY2023 | $6.28 | -6.7% |
| FY2022 | $6.73 | +0.1% |
| FY2021 | $6.72 | +17.8% |
| FY2020 | $5.71 | +68.5% |
| FY2019 | $3.39 | +2.6% |
| FY2018 | $3.30 | +6.2% |
| FY2017 | $3.11 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026